The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Pemphigoid, Bullous

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Pemphigoid, Bullous

 

High impact information on Pemphigoid, Bullous

 

Chemical compound and disease context of Pemphigoid, Bullous

 

Biological context of Pemphigoid, Bullous

 

Anatomical context of Pemphigoid, Bullous

 

Gene context of Pemphigoid, Bullous

 

Analytical, diagnostic and therapeutic context of Pemphigoid, Bullous

References

  1. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Liu, Z., Zhou, X., Shapiro, S.D., Shipley, J.M., Twining, S.S., Diaz, L.A., Senior, R.M., Werb, Z. Cell (2000) [Pubmed]
  2. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. Li, N., Zhao, M., Hilario-Vargas, J., Prisayanh, P., Warren, S., Diaz, L.A., Roopenian, D.C., Liu, Z. J. Clin. Invest. (2005) [Pubmed]
  3. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. Liu, Z., Diaz, L.A., Troy, J.L., Taylor, A.F., Emery, D.J., Fairley, J.A., Giudice, G.J. J. Clin. Invest. (1993) [Pubmed]
  4. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them. Sugi, T., Hashimoto, T., Hibi, T., Nishikawa, T. J. Clin. Invest. (1989) [Pubmed]
  5. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. Fiebiger, E., Hammerschmid, F., Stingl, G., Maurer, D. J. Clin. Invest. (1998) [Pubmed]
  6. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Guo, L., Degenstein, L., Dowling, J., Yu, Q.C., Wollmann, R., Perman, B., Fuchs, E. Cell (1995) [Pubmed]
  7. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. Anhalt, G.J., Kim, S.C., Stanley, J.R., Korman, N.J., Jabs, D.A., Kory, M., Izumi, H., Ratrie, H., Mutasim, D., Ariss-Abdo, L. N. Engl. J. Med. (1990) [Pubmed]
  8. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. Liu, Z., Shipley, J.M., Vu, T.H., Zhou, X., Diaz, L.A., Werb, Z., Senior, R.M. J. Exp. Med. (1998) [Pubmed]
  9. Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. Liu, Z., Roopenian, D.C., Zhou, X., Christianson, G.J., Diaz, L.A., Sedmak, D.D., Anderson, C.L. J. Exp. Med. (1997) [Pubmed]
  10. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. Büdinger, L., Borradori, L., Yee, C., Eming, R., Ferencik, S., Grosse-Wilde, H., Merk, H.F., Yancey, K., Hertl, M. J. Clin. Invest. (1998) [Pubmed]
  11. Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Meisel, J.L., Perera, D.R., Meligro, C., Rubin, C.E. Gastroenterology (1976) [Pubmed]
  12. Bullous pemphigoid treated with mycophenolate mofetil. Böhm, M., Beissert, S., Schwarz, T., Metze, D., Luger, T. Lancet (1997) [Pubmed]
  13. Effects of cyclosporin on bullous pemphigoid and pemphigus. Thivolet, J., Barthelemy, H., Rigot-Muller, G., Bendelac, A. Lancet (1985) [Pubmed]
  14. Immunochemical characterization of three components of the hemidesmosome and their expression in cultured epithelial cells. Klatte, D.H., Kurpakus, M.A., Grelling, K.A., Jones, J.C. J. Cell Biol. (1989) [Pubmed]
  15. C3d,g is present in normal human epidermal basement membrane. Basset-Seguin, N., Dersookian, M., Cehrs, K., Yancey, K.B. J. Immunol. (1988) [Pubmed]
  16. The human 230-kD bullous pemphigoid antigen gene (BPAG1). Exon-intron organization and identification of regulatory tissue specific elements in the promoter region. Tamai, K., Sawamura, D., Do, H.C., Tamai, Y., Li, K., Uitto, J. J. Clin. Invest. (1993) [Pubmed]
  17. Targeting C5a: recent advances in drug discovery. Allegretti, M., Moriconi, A., Beccari, A.R., Di Bitondo, R., Bizzarri, C., Bertini, R., Colotta, F. Current medicinal chemistry. (2005) [Pubmed]
  18. Redistribution of the hemidesmosome components alpha 6 beta 4 integrin and bullous pemphigoid antigens during epithelial wound healing. Gipson, I.K., Spurr-Michaud, S., Tisdale, A., Elwell, J., Stepp, M.A. Exp. Cell Res. (1993) [Pubmed]
  19. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. Fairley, J.A., Fu, C.L., Giudice, G.J. J. Invest. Dermatol. (2005) [Pubmed]
  20. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. Zillikens, D., Caux, F., Mascaro, J.M., Wesselmann, U., Schmidt, E., Prost, C., Callen, J.P., Bröcker, E.B., Diaz, L.A., Giudice, G.J. J. Invest. Dermatol. (1999) [Pubmed]
  21. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. Diaz, L.A., Ratrie, H., Saunders, W.S., Futamura, S., Squiquera, H.L., Anhalt, G.J., Giudice, G.J. J. Clin. Invest. (1990) [Pubmed]
  22. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin. Hopkinson, S.B., Baker, S.E., Jones, J.C. J. Cell Biol. (1995) [Pubmed]
  23. Identification of an epitope within human integrin alpha 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid. Rashid, K.A., Stern, J.N., Ahmed, A.R. J. Immunol. (2006) [Pubmed]
  24. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. Thoma-Uszynski, S., Uter, W., Schwietzke, S., Schuler, G., Borradori, L., Hertl, M. J. Immunol. (2006) [Pubmed]
  25. Genomic organization of collagenous domains and chromosomal assignment of human 180-kDa bullous pemphigoid antigen-2, a novel collagen of stratified squamous epithelium. Li, K.H., Sawamura, D., Giudice, G.J., Diaz, L.A., Mattei, M.G., Chu, M.L., Uitto, J. J. Biol. Chem. (1991) [Pubmed]
  26. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. Schmidt, E., Reimer, S., Kruse, N., Jainta, S., Bröcker, E.B., Marinkovich, M.P., Giudice, G.J., Zillikens, D. J. Invest. Dermatol. (2000) [Pubmed]
  27. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. Teraki, Y., Hotta, T., Shiohara, T. J. Invest. Dermatol. (2001) [Pubmed]
  28. Regional variation in the expression of bullous pemphigoid antigen and location of lesions in bullous pemphigoid. Goldberg, D.J., Sabolinski, M., Bystryn, J.C. J. Invest. Dermatol. (1984) [Pubmed]
  29. IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein. Zone, J.J., Taylor, T.B., Kadunce, D.P., Chorzelski, T.P., Schachner, L.A., Huff, J.C., Meyer, L.J., Petersen, M.J. J. Invest. Dermatol. (1996) [Pubmed]
  30. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. Haase, C., Büdinger, L., Borradori, L., Yee, C., Merk, H.F., Yancey, K., Hertl, M. J. Invest. Dermatol. (1998) [Pubmed]
  31. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. Di Zenzo, G., Grosso, F., Terracina, M., Mariotti, F., De Pità, O., Owaribe, K., Mastrogiacomo, A., Sera, F., Borradori, L., Zambruno, G. J. Invest. Dermatol. (2004) [Pubmed]
  32. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. Baird, J., Lazarus, G.S., Belin, D., Vassalli, J.D., Busso, N., Gubler, P., Jensen, P.J. J. Invest. Dermatol. (1990) [Pubmed]
 
WikiGenes - Universities